Owner The Government of the United States as represented by the Secretary of the Department of Health and Human Services

Inventors Fitzgerald, David

Agent Davies Collison Cave

Pub. Number AU-B-2002248209

PCT Pub. Number WO2002/060935

Priority 60/257,877 21.12.00 US

Filing date 20 December 2001

Wipo publication date 12 August 2002

Acceptance publication date 27 September 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/21 (2006.01) Peptides having more than 20 amino acids

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

C07K 14/28 (2006.01) Peptides having more than 20 amino acids

C07K 14/285 (2006.01) Peptides having more than 20 amino acids

C07K 14/40 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies